EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Germline BRCA2 variant with low variant allele frequency detected in tumor‐only comprehensive genomic profiling

Hideyuki Hayashi iD, Kei Kunimasa, Shigeki Tanishima, Kohei Nakamura iD, Marin Ishikawa, Yasutaka Kato, Eriko Aimono, Ryutaro Kawano, Hiroshi Nishihara

Cancer Science · 2024

DOI: 10.1111/cas.16043 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cancer Science, 2024. Verfasst von Hideyuki Hayashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: BRCA2 Protein, Sarcoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Japan Society for the Promotion of Science KAKENHI (Grant-in-Aid for Early-Career Scientists).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Germline BRCA1/2 variants in comprehensive genomic profiling (CGP) often exhibit variant allele frequency (VAF) exceeding 50%. However, when genomic loss occurs at the ipsilateral allele, including the germline variant in tumor cells, the VAF is low. This case report presents a patient with uterine sarcoma with a pathogenic BRCA2 mutation and low VAF in tumor‐only CGP, which was later identified as a germline variant. When genomic alterations in BRCA1/2 are identified in tumor‐only CGP, the possible germline origin of the variants should be considered, even if their VAF is very low.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA2 ProteinSarcomaHumansBRCA1 ProteinGenetic Predisposition to DiseaseGene FrequencyGenomicsGerm CellsGerm-Line Mutation

Stichwörter der Autor:innen

BRCAPARP inhibitorgenomic losslow VAFtumor-only CGP

Substanzen

BRCA2 protein, humanBRCA2 ProteinBRCA1 protein, humanBRCA1 Protein

Autor:innen und Institutionen

  • Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan.
  • Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Department of Biomedical Informatics Development, Mitsubishi Electric Software Co., Ltd, Tokyo, Japan.

ORCID-Profile: Hideyuki Hayashi, Kohei Nakamura

Förderung

  • the Japan Society for the Promotion of Science KAKENHI (Grant-in-Aid for Early-Career Scientists)

Zitieren

APA

Hayashi, H., Kunimasa, K., Tanishima, S., Nakamura, K., Ishikawa, M., Kato, Y., Aimono, E., Kawano, R., & Nishihara, H. (2024). Germline BRCA2 variant with low variant allele frequency detected in tumor‐only comprehensive genomic profiling. Cancer Science. https://doi.org/10.1111/cas.16043

Vancouver

Hayashi H, Kunimasa K, Tanishima S, Nakamura K, Ishikawa M, Kato Y, et al. Germline BRCA2 variant with low variant allele frequency detected in tumor‐only comprehensive genomic profiling. Cancer Science. 2024. doi:10.1111/cas.16043

BibTeX
@article{Hayashi2024,
  author = {Hayashi, Hideyuki and Kunimasa, Kei and Tanishima, Shigeki and Nakamura, Kohei and Ishikawa, Marin and Kato, Yasutaka and Aimono, Eriko and Kawano, Ryutaro and Nishihara, Hiroshi},
  title = {Germline BRCA2 variant with low variant allele frequency detected in tumor‐only comprehensive genomic profiling},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16043}
}
Kostenlos starten →